SEC Form 4 · accession 0001209191-15-055370
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick G Enright
Director · 10% Owner
Period of report
Jun 18, 2015
Accepted (ET)
Jun 22, 2015 · 4:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $6.55 | Jun 18, 2015 | A | 30,000 | A | — | Jun 18, 2025 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1The vesting period of the shares underlying the option commenced on the date of grant, with 8.3334% of the shares to vest on each monthly anniversary of the grant date and the final vesting of all remaining shares to occur on or before the date of the Issuer's 2016 Annual Meeting of Stockholders. The reporting person shares pecuniary interest in these securities with other individuals pursuant to a contractual relationship. The reporting person disclaims beneficial ownership of these securities except as to the extent of the reporting person's pecuniary interest in these securities.